Sylviane Olschwang

Summary

Country: France

Publications

  1. ncbi SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis
    Guillaume Rousseau
    Laboratory of Molecular Oncogenetics, Institut Paoli Calmettes, Marseille, France
    BMC Neurol 11:9. 2011
  2. ncbi [Early-onset colorectal carcinoma study]
    Janick Selves
    J Selves Inserm U563, CPTP, CHU Purpan, BP 3028, 31024 Toulouse Cedex 3
    Med Sci (Paris) 25:25-8. 2009
  3. ncbi The LKB1 complex-AMPK pathway: the tree that hides the forest
    Michael Sebbagh
    INSERM, U891, Centre de Recherche en Cancerologie de Marseille, 27 Blv Lei Roure, 13009, Marseille, France
    Fam Cancer 10:415-24. 2011
  4. ncbi Germline APC mutation spectrum derived from 863 genomic variations identified through a 15-year medical genetics service to French patients with FAP
    Arnaud Lagarde
    Centre de Recherche en Cancérologie de Marseille INSERM UMR891, Marseille, France
    J Med Genet 47:721-2. 2010
  5. ncbi BRAF p.Val600Glu (V600E) somatic mutation is mainly associated with MSS phenotype in metastatic colorectal cancer
    Jinghua Qiu
    Institut Paoli Calmettes, Marseille, France
    Cancer Genomics Proteomics 8:15-8. 2011

Collaborators

  • Anthony Goncalves
  • Etienne Rouleau
  • Daniel Birnbaum
  • Janick Selves
  • Jinghua Qiu
  • Arnaud Lagarde
  • Guillaume Rousseau
  • Michael Sebbagh
  • Tetsuro Noguchi
  • Violaine Bourdon
  • Hagay Sobol
  • Luc Xerri
  • Jean Paul Borg
  • Olivier Turrini
  • Sophy Laibe
  • Marie Josée Santoni
  • Marion Compagnone
  • Genevieve Monges
  • José Adélaïde
  • Pascaline Gaildrat
  • Adrien Briaux
  • Virginie Remy
  • Anthony Ferrari
  • Rosette Lidereau

Detail Information

Publications5

  1. ncbi SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis
    Guillaume Rousseau
    Laboratory of Molecular Oncogenetics, Institut Paoli Calmettes, Marseille, France
    BMC Neurol 11:9. 2011
    ..In contrast, germline mutations of the SMARCB1 (INI1) tumor suppressor gene were described in familial and sporadic schwannomatosis patients...
  2. ncbi [Early-onset colorectal carcinoma study]
    Janick Selves
    J Selves Inserm U563, CPTP, CHU Purpan, BP 3028, 31024 Toulouse Cedex 3
    Med Sci (Paris) 25:25-8. 2009
    ..The next step will consist in validating a molecular signature specific for early-onset carcinoma. Genomic profile does not differ from that observed in late-onset colon cancers...
  3. ncbi The LKB1 complex-AMPK pathway: the tree that hides the forest
    Michael Sebbagh
    INSERM, U891, Centre de Recherche en Cancerologie de Marseille, 27 Blv Lei Roure, 13009, Marseille, France
    Fam Cancer 10:415-24. 2011
    ..This review will discuss about LKB1 activity regulation, its effectors and clues on their involvement in cell polarity...
  4. ncbi Germline APC mutation spectrum derived from 863 genomic variations identified through a 15-year medical genetics service to French patients with FAP
    Arnaud Lagarde
    Centre de Recherche en Cancérologie de Marseille INSERM UMR891, Marseille, France
    J Med Genet 47:721-2. 2010
    ..The work presented here delineates precisely the APC mutation spectrum from 15 years of systematic molecular screening which identified 863 independent alterations in the French population...
  5. ncbi BRAF p.Val600Glu (V600E) somatic mutation is mainly associated with MSS phenotype in metastatic colorectal cancer
    Jinghua Qiu
    Institut Paoli Calmettes, Marseille, France
    Cancer Genomics Proteomics 8:15-8. 2011
    ..The impact of BRAF V600E mutation is not well documented...